• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

ASO Author Reflections: Impact of Neoadjuvant Therapy on Survival After Margin-Positive Resection for Pancreatic Cancer.

作者信息

Chopra Asmita, Beane Joal D

机构信息

Department of Surgery, University of Pittsburgh, Pittsburgh, PA, USA.

Department of Surgery, University of Toledo, Toledo, OH, USA.

出版信息

Ann Surg Oncol. 2021 Nov;28(12):7770-7771. doi: 10.1245/s10434-021-10177-w. Epub 2021 May 24.

DOI:10.1245/s10434-021-10177-w
PMID:34028634
Abstract
摘要

相似文献

1
ASO Author Reflections: Impact of Neoadjuvant Therapy on Survival After Margin-Positive Resection for Pancreatic Cancer.
Ann Surg Oncol. 2021 Nov;28(12):7770-7771. doi: 10.1245/s10434-021-10177-w. Epub 2021 May 24.
2
ASO Author Reflections: Neoadjuvant Therapy Versus Upfront Resection for Pancreatic Cancer.
Ann Surg Oncol. 2018 Dec;25(Suppl 3):810-811. doi: 10.1245/s10434-018-6874-y. Epub 2018 Oct 29.
3
ASO Author Reflections: Association Between Neoadjuvant Chemoradiotherapy and Intractable Serous Ascites After Pancreaticoduodenectomy for Pancreatic Cancer.
Ann Surg Oncol. 2021 Jul;28(7):3798-3799. doi: 10.1245/s10434-020-09413-6. Epub 2020 Nov 24.
4
ASO Author Reflections: Novel Evidence on Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer with Arterial Involvement.ASO作者反思：关于新辅助化疗治疗伴有动脉侵犯的可切除边缘胰腺癌的新证据
Ann Surg Oncol. 2023 Jan;30(1):203-204. doi: 10.1245/s10434-022-12584-z. Epub 2022 Sep 21.
5
ASO Author Reflections: Neoadjuvant Therapy for Pancreatic Cancer-Standard of Care or Still Worth Debating?ASO作者反思：胰腺癌新辅助治疗——护理标准还是仍值得商榷？
Ann Surg Oncol. 2020 Apr;27(4):1201-1202. doi: 10.1245/s10434-019-08135-8. Epub 2019 Dec 17.
6
ASO Author Reflections: Postoperative Chemotherapy After Neoadjuvant Therapy and Pancreatectomy for Pancreatic Cancer: Balancing Patient Physiology and Disease Biology.ASO作者反思：新辅助治疗和胰腺癌胰十二指肠切除术后的辅助化疗——平衡患者生理机能与疾病生物学特性
Ann Surg Oncol. 2021 Oct;28(11):6803-6804. doi: 10.1245/s10434-021-09896-x. Epub 2021 Mar 27.
7
Impact of resection margin status on survival in pancreatic cancer patients after neoadjuvant treatment and pancreatoduodenectomy.新辅助治疗和胰十二指肠切除术后，切缘状态对胰腺癌患者生存的影响。
Surgery. 2020 May;167(5):803-811. doi: 10.1016/j.surg.2019.12.008. Epub 2020 Jan 25.
8
ASO Author Reflections: Should we Stick our Neck Out for Pancreatic Neck Margins During Pancreaticoduodenectomy After Neoadjuvant Therapy?ASO作者反思：新辅助治疗后胰十二指肠切除术中，我们是否应该为胰腺颈部切缘冒险？
Ann Surg Oncol. 2022 Sep;29(9):6013-6014. doi: 10.1245/s10434-022-11843-3. Epub 2022 Apr 29.
9
ASO Author Reflections: Prognostic Index after Neoadjuvant Chemotherapy (PINC) in Pancreatic Ductal Adenocarcinoma as Novel Tumor Regression Grading System.ASO作者反思：胰腺导管腺癌新辅助化疗后的预后指数（PINC）作为新型肿瘤消退分级系统
Ann Surg Oncol. 2022 Jun;29(6):3503. doi: 10.1245/s10434-022-11461-z. Epub 2022 Feb 20.
10
ASO Author Reflections: Neoadjuvant Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma-Predictors of Disease Progression and Performance Status Decline.ASO作者反思：局部胰腺导管腺癌的新辅助化疗——疾病进展和体能状态下降的预测因素
Ann Surg Oncol. 2020 Aug;27(8):2972-2973. doi: 10.1245/s10434-020-08299-8. Epub 2020 Mar 2.

本文引用的文献

1
Survival benefit of neoadjuvant therapy in patients with non-metastatic pancreatic ductal adenocarcinoma: A propensity matching and intention-to-treat analysis.新辅助治疗对非转移性胰腺导管腺癌患者生存获益的影响：倾向评分匹配和意向治疗分析。
J Surg Oncol. 2019 Nov;120(6):976-984. doi: 10.1002/jso.25681. Epub 2019 Aug 26.
2
Is early-stage pancreatic adenocarcinoma truly early: stage migration on final pathology with surgery-first versus neoadjuvant therapy sequencing.早期胰腺腺癌真的早期吗：手术优先与新辅助治疗序贯治疗后最终病理分期迁移。
HPB (Oxford). 2019 Sep;21(9):1203-1210. doi: 10.1016/j.hpb.2019.01.011. Epub 2019 Feb 22.
3
Clinical Impact of Neoadjuvant Chemotherapy and Chemoradiotherapy in Borderline Resectable Pancreatic Cancer: Analysis of 884 Patients at Facilities Specializing in Pancreatic Surgery.
新辅助化疗和放化疗对边界可切除胰腺癌的临床影响：884 例胰腺外科专科医院患者的分析。
Ann Surg Oncol. 2019 Jun;26(6):1629-1636. doi: 10.1245/s10434-018-07131-8. Epub 2019 Jan 4.
4
The impact of neoadjuvant therapy on the histopathological features of pancreatic ductal adenocarcinoma - A systematic review and meta-analysis.新辅助治疗对胰腺导管腺癌组织病理学特征的影响 - 系统评价和荟萃分析。
Cancer Treat Rev. 2017 Apr;55:96-106. doi: 10.1016/j.ctrv.2017.03.003. Epub 2017 Mar 14.
5
Pancreatic Cancer Surgery: The New R-status Counts.胰腺癌手术：新的R状态计数法
Ann Surg. 2017 Mar;265(3):565-573. doi: 10.1097/SLA.0000000000001731.